Literature DB >> 24924406

Investigating facial affect processing in psychosis: a study using the Comprehensive Affective Testing System.

Susan L Rossell1, Tamsyn E Van Rheenen2, Nicole R Joshua3, Alison O'Regan4, Andrea Gogos3.   

Abstract

Facial affect processing (FAP) deficits in schizophrenia (SZ) and bipolar disorder (BD) have been widely reported; although effect sizes vary across studies, and there are limited direct comparisons of the two groups. Further, there is debate as to the influence of both psychotic and mood symptoms on FAP. This study aimed to address these limitations by recruiting groups of psychosis patients with either a diagnosis of SZ or BD and comparing them to healthy controls (HC) on a well validated battery of four FAP subtests: affect discrimination, name affect, select affect and match affect. Overall, both groups performed more poorly than controls in terms of accuracy. In SZ, this was largely driven by impairments on three of the four subtests. The BD patients showed impaired performance specifically on the match affect subtest, a task that had a high cognitive load. FAP performance in the psychosis patients was correlated with severity of positive symptoms and mania. This study confirmed that FAP deficits are a consistent finding in SZ that occur independent of task specific methodology; whilst FAP deficits in BD are more subtle. Further work in this group is needed to replicate these results.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Facial affect processing; Mania; Schizophrenia; Social cognition

Mesh:

Year:  2014        PMID: 24924406     DOI: 10.1016/j.schres.2014.05.026

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  1 in total

1.  Association Between Psychosis in Elderly Patients With Alzheimer Disease and Impaired Social Cognition.

Authors:  Jeremy Koppel; Amber Sousa; Marc L Gordon; Luca Giliberto; Erica Christen; Peter Davies
Journal:  JAMA Psychiatry       Date:  2018-06-01       Impact factor: 21.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.